Fisher Asset Management LLC boosted its holdings in CVS Health Corporation (NYSE:CVS – Free Report) by 6.4% during the third quarter, HoldingsChannel reports. The fund owned 97,886 shares of the pharmacy operator’s stock after buying an additional 5,876 shares during the period. Fisher Asset Management LLC’s holdings in CVS Health were worth $8,388,000 at the end of the most recent quarter.
Several other hedge funds also recently added to or reduced their stakes in CVS. Kilter Group LLC acquired a new stake in CVS Health during the second quarter worth $27,000. Beaird Harris Wealth Management LLC lifted its stake in shares of CVS Health by 201.0% in the 2nd quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 195 shares during the last quarter. J.Safra Asset Management Corp acquired a new position in shares of CVS Health in the 2nd quarter valued at $30,000. Timbuktu Capital Management LLC purchased a new position in shares of CVS Health during the 2nd quarter worth $31,000. Finally, Dunhill Financial LLC purchased a new position in shares of CVS Health during the 2nd quarter worth $32,000. 80.66% of the stock is currently owned by hedge funds and other institutional investors.
CVS Health Trading Up 0.0%
CVS opened at $89.37 on Monday. CVS Health Corporation has a 52 week low of $69.51 and a 52 week high of $110.68. The company has a quick ratio of 0.66, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The business has a fifty day simple moving average of $89.65 and a 200-day simple moving average of $89.09. The firm has a market cap of $114.34 billion, a P/E ratio of 10.40, a P/E/G ratio of 0.78 and a beta of 0.58.
CVS Health (NYSE:CVS – Get Free Report) last posted its quarterly earnings data on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.65 by $0.44. CVS Health had a return on equity of 13.65% and a net margin of 2.62%. The firm had revenue of $108.40 billion for the quarter, compared to the consensus estimate of $104.72 billion. During the same quarter in the previous year, the business earned $1.60 EPS. The company’s quarterly revenue was up 5.4% compared to the same quarter last year. On average, equities analysts expect that CVS Health Corporation will post 8.26 earnings per share for the current year.
CVS Health Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd were given a $0.6650 dividend. This represents a $2.66 annualized dividend and a yield of 3.0%. The ex-dividend date of this dividend was Thursday, October 22nd. CVS Health’s payout ratio is currently 30.97%.
Analyst Upgrades and Downgrades
CVS has been the topic of several research analyst reports. Wells Fargo & Company reduced their price objective on shares of CVS Health from $123.00 to $112.00 and set an “overweight” rating on the stock in a report on Thursday. Piper Sandler set a $106.00 target price on shares of CVS Health in a research report on Friday. Robert W. Baird set a $107.00 target price on shares of CVS Health in a research note on Thursday, August 6th. Leerink Partners dropped their price target on shares of CVS Health from $112.00 to $104.00 and set an “outperform” rating for the company in a research report on Thursday, November 5th. Finally, Jefferies Financial Group reissued a “buy” rating and issued a $103.00 price target on shares of CVS Health in a research note on Wednesday, November 4th. Twenty-three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $107.54.
Get Our Latest Research Report on CVS
Recent CVS Health Headlines
Investors following CVS have been watching these headlines:
- Positive Sentiment: A separation could give the pharmacy business and CVS’s other operations sharper strategic focus and improve capital allocation. Some analysts see potential for the pieces to be worth more separately, though the plan is not expected until 2028. CVS Breakup Won’t Satisfy Washington. It Could Still Work for Wall Street.
- Positive Sentiment: CVS’s recent quarterly results were strong: earnings of $2.09 per share exceeded the $1.65 consensus estimate, while revenue also topped expectations. CVS Beat Earnings by 27% and Split in Two
- Neutral Sentiment: Wells Fargo lowered its price target to $112 from $123 but kept an Overweight rating, signaling a reduced valuation outlook while still seeing potential upside. Wells Fargo analyst rating
Insiders Place Their Bets
In other CVS Health news, EVP Prem Shah purchased 23,855 shares of the business’s stock in a transaction on Friday, November 6th. The shares were bought at an average cost of $83.89 per share, for a total transaction of $2,001,195.95. Following the completion of the purchase, the executive vice president directly owned 88,516 shares of the company’s stock, valued at approximately $7,425,607.24. This trade represents a 36.89% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.85% of the stock is currently owned by corporate insiders.
CVS Health Profile
CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.
Read More
- Five stocks we like better than CVS Health
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
